TCG Crossover Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001839948

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q4 2025 · 43 positions · Total reported value $3.02B · Top-10 concentration 64.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 44.3% · 7 new · 15 cut · 5 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.6% · vs SPY -9.8% · Prev Value $4.16B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.9% · vs SPY -5.0% · Latest Value $3.54B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2025 13F filing, TCG Crossover Management, LLC disclosed 43 equity positions with a combined reported value of $3.02B. The filing implies a focused portfolio: its ten largest positions account for 64.3% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2025 were ABVX ($959.03M), COGT ($208.44M), CGON ($152.39M). By sector, the heaviest allocations are Health Care 91.3%, Industrials 2.2%. Versus the prior quarter, allocation shifted toward Health Care (+4.1pp) and away from Other (-3.8pp).

Versus the prior quarter, TCG Crossover Management, LLC opened 7 new positions, trimmed 15 and fully exited 5, a turnover rate of 44.3% of positions. The portfolio's overlap with the prior quarter was 73% of names.

The largest new positions opened in Q4 2025 were GLUE ($72.48M), BHVN ($52.29M), IMVT ($42.22M).

Of the 5 positions fully exited versus the prior quarter, the largest were TRML ($62.74M), IRON ($30.74M), ATXS ($20.11M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • GLUE MONTE ROSA THERAPEUTICS INC · $72.48M
  • BHVN BIOHAVEN LTD · $52.29M
  • IMVT IMMUNOVANT INC · $42.22M
  • JANX JANUX THERAPEUTICS INC · $24.70M
  • ALEC ALECTOR INC · $15.60M
  • MAZE MAZE THERAPEUTICS INC · $7.20M
  • MIRM MIRUM PHARMACEUTICALS INC · $4.90M
  • LONA LEONABIO INC · $3.35M

Fully Exited (vs previous quarter)

  • TRML TOURMALINE BIO INC · prev qtr: $62.74M
  • IRON DISC MEDICINE INC · prev qtr: $30.74M · history
  • ATXS ASTRIA THERAPEUTICS INC · prev qtr: $20.11M
  • ADVM ADVERUM BIOTECHNOLOGIES INC · prev qtr: $7.56M
  • PEPG PEPGEN INC · prev qtr: $5.54M

Insider Transactions (Form 4)

Latest TCG Crossover Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

TCG Crossover Management, LLC, based in Palo Alto, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 54 positions worth $4.16B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: PALO ALTO, CA, United States
  • SEC registration: 801-120001 (status: Approved), registered 2020-12-18
  • Regulatory AUM (Form ADV): $5.06B as of 2026-05-29
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds
  • Website: tcgcrossover.com

Portfolio Structure

  • 54 positions · $4.16B reported value (Q2 2026)
  • Top 10 holdings = 57.4% of reported value
  • Largest position: ABVX (ABIVAX SA) at 19.2%
  • Average position size: $77.05M

Sector Tilt

  • Health Care 99.3%
  • Financials 0.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 12 new, 2 added, 9 reduced, 7 exited
  • 31 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 91.3%
Other 6.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 7.11M $959.03M 31.74%
31.74%
Hold
2 5.87M $208.44M 6.90%
6.90%
Reduce
3 3.67M $152.39M 5.04%
5.04%
Hold
4 12.76M $113.07M 3.74%
3.74%
Add
5 4.29M $107.20M 3.55%
3.55%
Add
6 4.62M $90.27M 2.99%
2.99%
Hold
7 2.58M $87.47M 2.90%
2.90%
Add
8 2.90M $76.19M 2.52%
2.52%
Hold
9 6.24M $75.43M 2.50%
2.50%
Hold
10 12.36M $74.54M 2.47%
2.47%
Hold
11 4.62M $72.48M 2.40%
2.40%
New
12 5.74M $69.69M 2.31%
2.31%
Reduce
13 1.68M $69.09M 2.29%
2.29%
Hold
14 3.57M $65.27M 2.16%
2.16%
Hold
15 920.86K $64.05M 2.12%
2.12%
Reduce
16 1.90M $62.26M 2.06%
2.06%
Add
17 5.25M $59.38M 1.97%
1.97%
Hold
18 1.71M $58.98M 1.95%
1.95%
Hold
19 4.63M $52.29M 1.73%
1.73%
New
20 1.66M $42.22M 1.40%
1.40%
New
21 1.45M $40.42M 1.34%
1.34%
Add
22 11.39M $40.21M 1.33%
1.33%
Add
23 1.75M $38.84M 1.29%
1.29%
Hold
24 2.45M $37.54M 1.24%
1.24%
Hold
25 436.47K $34.77M 1.15%
1.15%
Hold
26 1.18M $32.17M 1.06%
1.06%
Reduce
27 2.67M $31.62M 1.05%
1.05%
Add
28 3.22M $27.24M 0.90%
0.90%
Add
29 1.79M $24.70M 0.82%
0.82%
New
30 2.09M $21.47M 0.71%
0.71%
Add
31 650.00K $20.50M 0.68%
0.68%
Hold
32 743.89K $20.20M 0.67%
0.67%
Reduce
33 3.03M $18.44M 0.61%
0.61%
Hold
34 717.35K $16.80M 0.56%
0.56%
Hold
35 10.00M $15.60M 0.52%
0.52%
New
36 141.91K $9.27M 0.31%
0.31%
Reduce
37 483.00K $8.77M 0.29%
0.29%
Hold
38 173.82K $7.20M 0.24%
0.24%
New
39 62.05K $4.90M 0.16%
0.16%
New
40 464.40K $3.35M 0.11%
0.11%
New
41 416.30K $3.33M 0.11%
0.11%
Hold
42 316.19K $2.86M 0.09%
0.09%
Hold
43 2.68M $1.77M 0.06%
0.06%
Hold

FAQ

What did TCG Crossover Management, LLC buy in 2025-Q4?

In its 2025-Q4 13F filing, TCG Crossover Management, LLC reported 43 equity positions worth $3.02B in aggregate; its largest disclosed positions were ABVX ($959.03M), COGT ($208.44M), CGON ($152.39M).

How large is TCG Crossover Management, LLC's portfolio?

TCG Crossover Management, LLC reported $3.02B of long equity holdings across 43 positions as of 2025-Q4. Top-10 holdings account for 64.3% of reported value.

What is TCG Crossover Management, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tcg-crossover-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →